基因检测预测华法林给药剂量准确性的研究
[Abstract]:Objective: to investigate the correlation between the predicted dose of warfarin IWPC and the actual dose. Methods: 97 patients with warfarin gene were selected from a hospital from November 2014 to August 2015, and their basic information and clinical drug use were recorded. The genotypes of CYP2C9O2KORGA-3 and VKORC1 were detected by gene sequencing. The IWPC formula was used to predict the warfarin dose and the correlation between the predicted dose and the actual dose was investigated. Results: 73 of 97 patients who took warfarin were treated with warfarin. The actual initial dose of CYP2C9 / 3 AAVKORC1 AA in the predicted dose range was 81.13% (43 / 53 cases), and the actual initial dose of CYP2C9 / ACVKORC1 AA was 62.50% (58 / 8) within the predicted dose range, and the actual initial dose of the remaining genotypes was in the pre-dose range of 62.50% (58 cases). The ratio within the range of the measured dose is small. In the maintenance dose, the average value of the predicted weekly dose was 19.286 mg, and the average of the actual maintenance weekly dose was 19.958 mg / min. The predicted weekly maintenance dose was not significantly different from the actual maintenance weekly dose. The correlation coefficients between predicted dose and actual dose in VKORC1 AA / CYP2C9 / 3 AC and VKORC1 AGR / CYP2C9 / 3 AA2 groups were 0.537 and 0.916, respectively. Conclusion: the prediction of warfarin dosage by gene detection has some accuracy. In the initial dose prediction, CYP2C9 / VKORC1 AA and CYP2C9 / 3AC / VKORCAA type are higher than that in maintenance dose prediction, and the accuracy of CYP2C9 / VKORCAA and CYP2C93AAVKORC1 AG prediction is higher than that of CYP2C93ACVKORCAA and CYP2C93AAKORC1 AG. It has high clinical reference significance.
【作者单位】: 卫生部中日友好医院药学部;重庆新桥医院药学部;
【基金】:国家自然科学基金青年科学基金项目(编号:81401507) 中日友好医院院级科研基金资助课题(编号:2014-2-QN-18)
【分类号】:R969
【相似文献】
相关期刊论文 前9条
1 黎彬;;基因突变与抗肺癌药的作用效果密切相关[J];国外医学情报;2004年11期
2 袁素波,王治乔,叶常青,廖明阳,夏英,杨梅英;环磷酰胺诱导永生化人支气管上皮细胞恶性转化过程中的基因突变[J];中国药理学与毒理学杂志;2001年06期
3 曲守方;于婷;孙彬裕;孙楠;王菲菲;黄杰;高尚先;;人类K-ras基因突变质控品的建立[J];药物分析杂志;2013年10期
4 郭健;周彩存;张颉;唐亮;;EGFR基因突变与EGFR酪氨酸激酶抑制剂近期疗效的关系[J];中国肺癌杂志;2007年06期
5 张娜,罗春香;发现瘦素[J];湖南医学高等专科学校学报;2000年01期
6 林辉,彭孝纬,何利平,潘秀珍;rdxA基因在幽门螺杆菌对甲硝唑耐药机制中的作用[J];中华消化杂志;2003年06期
7 詹立,张立实,王莉,张浩,铃木孝昌,本间正充,吴德生;环磷酰胺诱导TK6细胞TK基因杂合性丢失的实验研究[J];四川大学学报(医学版);2005年03期
8 宋礼华,桂向东,徐键,范清林;一个新的经济增长点:生物医药产业的现状和发展趋势——兼论安徽省面临的机遇和应采取的对策[J];生物学杂志;1998年05期
9 ;[J];;年期
相关会议论文 前1条
1 张利红;石静;祭美菊;施秉银;侯鹏;;结节性甲状腺肿中药物代谢与转运相关基因启动子异常甲基化分析[A];中华医学会第十次全国内分泌学学术会议论文汇编[C];2011年
相关重要报纸文章 前3条
1 上海市儿童医院药学部 孙华君 邢文荣 李志玲;因人施治 从基因检测起步[N];健康报;2014年
2 刘霞;新型抗癌药物可阻断特定基因变异[N];科技日报;2010年
3 记者 张建松;硝酸甘油有效性受基因突变影响[N];新华每日电讯;2006年
相关硕士学位论文 前1条
1 王鸿;肿瘤个体化用药相关基因检测方法的应用与比较[D];西北大学;2012年
,本文编号:2127277
本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2127277.html